製药和生物技术领域的生产和供应协议（2021-2026）

全球生物製药产业生产与供应合作关係基准分析

"製药和生物技术领域的生产和供应协议" 报告对全球生命科学产业的生产和供应合作关係进行了全面分析。该报告专为业务拓展、授权和营运专业人士设计，深入剖析了企业如何建立生产协议、协商财务条款以及建立供应关係，以支援药物研发和商业化。

这份经过全面修订和更新的报告，提供了从 Current Agreements 的协议和合作关係资料库中提取的最新发布的生产和供应协议的完整清单。每份合约记录都包含可用的财务信息，以及指向详细线上合约记录和合约文件的链接，这些文件将在发布后提交给监管机构。

透过结合详细的合约资料、财务基准和实际合约文件的存取权限，本报告提供了宝贵的见解，可帮助您评估潜在合作伙伴、建立供应协议并协商更有效的生产合作关係。

主要优势

• 显着缩短研究时间

您无需搜寻多个资料库、新闻稿和监管文件，即可存取统一的生产和供应协议资料库。

• 生产与供应协议结构基准分析

您可以了解製药和生技公司如何建立其生产和供应合作关係，包括责任、分工和长期供应协议。

• 自信地分析财务条款

您可以查看已揭露的财务条款和交易价值，并对类似的商业结构进行基准分析。生产协议。

• 查阅实际合约文件

如有需要，您可以查阅已向美国证券交易委员会 (SEC) 提交的生产和供应协议，深入了解实际合作关係背后的详细合约条款。

• 识别主要生产和供应承包公司

识别生产合作关係中最活跃的公司，并分析其外包和供应链策略。

• 追踪产业趋势

依公司、治疗领域和技术类型分析生产和供应承包趋势，了解外包和生产策略的演变。

回报内容

生产与供应承包趋势分析

生产和供应合约结构概述

主要生产和供应合约回顾价值

最活跃的生产和供应合约公司简介

依公司、治疗领域、技术类型和行业分类的交易详细分析

目前：包含协议资料库中註册的生产和供应协议的综合合约目录。

线上交易记录和合约文件的连结（如有）

基于实际合约的尽职调查见解

本报告使用户能够评估关键的合作条款，例如：

• 生产责任与生产承诺
• 供应条款和商业义务
• 财务支付结构与定价机制
• 独家条款与地理供应权
• 品质控制与监管合规责任
• 合约期限和终止条款
• 合约文件提供了合作伙伴之间协商的详细条款的关键资讯。 这些资讯通常无法在新闻稿或传统交易资料库中找到。
• 本报告的重要性
• 生产和供应合作关係对于医药和生物技术产品的成功开发和商业化至关重要。企业越来越依赖外部合作伙伴来扩大生产规模、提升产能并取得专业製造技术。 本报告提供全面的交易数据、财务基准以及实际合约文件的存取权限，从而提供建立更强大的生产合作伙伴关係、评估外包策略以及谈判有效供应合约所需的洞察。

目录

摘要整理

第一章：引言

第二章：製造与供应交易趋势

• 引言
• 製造与供应合约的定义
• 2021年以来製造与供应合约的趋势
  • 依年份划分的製造与供应合约
  • 依研发阶段划分的製造与供应合约
  • 依行业划分的製造与供应合约
  • 依治疗领域划分的製造与供应合约
  • 依技术类型划分的製造与供应合约
  • 依最活跃公司划分的製造与供应合约
• 签订製造与供应合作协议的原因
• 製造业的未来製造与供应合约

第三章 製造与供应合约架构概述

• 引言
• 製造与供应合约结构

第四章 - 主要製造与供应合约

• 引言
• 依价值排名的顶级製造与供应合同

第五章 - 最活跃的25家製造与供应合约公司

• 引言
• 最活跃的25家製造与供应合约公司

第六章 - 製造与供应合约（含合约目录）

• 引言
• 依合约类型分类的製造与供应合约
• 交易目录
• 依公司分类的製造与供应合约交易目录（AZ）
• 製造与供应合约交易目录依治疗领域分类
• 交易目录 - 依技术类型分类的生产和供应合约
• 关于研究公司
• 当前合作伙伴关係
• 当前合约
• 近期合作伙伴发布的报告标题

Benchmark Manufacturing and Supply Partnerships Across the Global Biopharma Industry

The Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology report provides a comprehensive analysis of manufacturing and supply partnerships across the global life sciences industry. Designed for business development, licensing, and operations professionals, the report delivers detailed insight into how companies structure manufacturing agreements, negotiate financial terms, and establish supply relationships to support drug development and commercialization.

Fully revised and updated, the report provides a comprehensive listing of manufacturing and supply deals announced in recent years, drawn from the Current Agreements deals and alliances database. Each deal record includes financial information where available and links to detailed online deal records and contract documents filed with regulators when publicly disclosed.

By combining detailed deal data, financial benchmarking, and access to real contract documents, the report provides valuable intelligence for evaluating potential partners, structuring supply agreements, and negotiating more effective manufacturing partnerships.

Key Benefits

• Save Significant Research Time

Access a consolidated database of manufacturing and supply agreements instead of searching multiple databases, press releases, and regulatory filings.

• Benchmark Manufacturing and Supply Deal Structures

Understand how pharmaceutical and biotechnology companies structure manufacturing and supply partnerships, including responsibilities, operational roles, and long-term supply arrangements.

• Analyze Financial Terms with Confidence

Review disclosed financial terms and transaction values to benchmark the commercial structure of comparable manufacturing agreements.

• Access Real Contract Documents

Where available, explore SEC-filed manufacturing and supply agreements, providing deeper insight into the detailed contractual provisions behind real-world partnerships.

• Identify Leading Manufacturing and Supply Dealmakers

Discover which companies are most active in manufacturing partnerships and analyze their outsourcing and supply chain strategies.

• Track Industry Trends

Analyze manufacturing and supply dealmaking trends across companies, therapeutic areas, and technology types to understand how outsourcing and production strategies are evolving.

What's Included in the Report

Analysis of manufacturing and supply dealmaking trends

Overview of manufacturing and supply agreement structures

Review of the leading manufacturing and supply deals by value

Profiles of the most active manufacturing and supply dealmakers

Detailed analysis of deals organized by company, therapeutic area, technology type, and industry sector

A comprehensive deal directory covering manufacturing and supply agreements recorded in the Current Agreements database

Links to online deal records and contract documents where available

Due Diligence Insights from Real Agreements

By reviewing actual manufacturing and supply contracts, the report enables users to evaluate key partnership provisions such as:

• Manufacturing responsibilities and production commitments
• Supply terms and commercial obligations
• Financial payment structures and pricing mechanisms
• Exclusivity provisions and territorial supply rights
• Quality control and regulatory compliance responsibilities
• Contract duration and termination provisions
• Contract documents provide critical insight into the detailed terms negotiated between partners-information that is often not available in press releases or traditional deal databases.
• Why This Report Matters
• Manufacturing and supply partnerships are essential to the successful development and commercialization of pharmaceutical and biotechnology products. Companies increasingly rely on external partners to scale production, expand capacity, and access specialized manufacturing technologies.
• By providing comprehensive deal data, financial benchmarking, and access to real contract documents, this report delivers the intelligence needed to structure stronger manufacturing partnerships, evaluate outsourcing strategies, and negotiate more effective supply agreements.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in manufacturing and supply dealmaking

• 2.1. Introduction
• 2.2. Definition of manufacturing and supply deal
• 2.3. Trends in manufacturing and supply deals since 2021
  • 2.3.1. Manufacturing and supply dealmaking by year
  • 2.3.2. manufacturing and supply dealmaking by phase of development
  • 2.3.3. Manufacturing and supply dealmaking by industry sector
  • 2.3.4. Manufacturing and supply dealmaking by therapy area
  • 2.3.5. Manufacturing and supply dealmaking by technology type
  • 2.3.6. Manufacturing and supply dealmaking by most active company
• 2.4. Reasons for entering into manufacturing and supply partnering deals
• 2.5. The future of manufacturing and supply deals

Chapter 3 - Overview of manufacturing and supply deal structure

• 3.1. Introduction
• 3.2. manufacturing and supply agreement structure

Chapter 4 - Leading manufacturing and supply deals

• 4.1. Introduction
• 4.2. Top manufacturing and supply deals by value

Chapter 5 - Top 25 most active manufacturing and supply dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active manufacturing and supply dealmakers

Chapter 6 - manufacturing and supply deals including contracts directory

• 6.1. Introduction
• 6.2. manufacturing and supply deals with contracts
• Deal directory
• Deal directory - manufacturing and supply dealmaking by companies A-Z
• Deal directory - manufacturing and supply dealmaking by therapy area
• Deal directory - manufacturing and supply dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of manufacturing and supply
• Figure 2: Trends in manufacturing and supply deal announcements
• Figure 3: Manufacturing and supply deals signed at each phase of development
• Figure 4: Manufacturing and supply deals by industry sector
• Figure 5: Manufacturing and supply deals by therapy area
• Figure 6: Manufacturing and supply deals by technology type
• Figure 7: Top 25 most active manufacturing and supply dealmakers
• Figure 8: Top manufacturing and supply deals by value
• Figure 9: Most active manufacturing and supply dealmakers